Evidence map›Paper›PMID 29493583›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Anticipating uncertainty and irrevocable decisions: provider perspectives on implementing whole-genome sequencing in critically ill children with heart disease.

Danton S Char, Sandra Soo-Jin Lee, David Magnus, Mildred Cho

Open access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. How Neonatologists Use Genetic Information.The Journal of pediatrics · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hospital-level variation in genetic testing in children's hospitals' neonatal intensive care units from 2016 to 2021.Genetics in medicine : official journal of the American College of Medical Genetics · 2023
    Article
  13. Review
  14. Article
  15. How neonatologists use genetic testing: findings from a national survey.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  16. Parental Attitudes Toward Clinical Genomic Sequencing in Children With Critical Cardiac Disease.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Privacy and ethical challenges in next-generation sequencing.Expert review of precision medicine and drug development · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Danton S CharDivision of Pediatric Cardiac Anesthesia, Department of Anesthesiology, Stanford University School of Medicine, Stanford, California, USA. dchar@stanford.edu.
Sandra Soo-Jin LeeCenter for Biomedical Ethics, Stanford University School of Medicine, Stanford, California, USA.
David MagnusCenter for Biomedical Ethics, Stanford University School of Medicine, Stanford, California, USA.
Mildred ChoCenter for Biomedical Ethics, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USStanford Medicine · US

Funding

Ethical challenges of whole genome sequencing in care of critically ill childrenK01HG008498 · NHGRI · STANFORD UNIVERSITY · PI CHAR, DANTON · 2015 to 2019
$1.2M
NHGRI NIH HHS K01 HG008498
6 · The paper itself

Abstract

purposeTo investigate the potential impacts of whole-genome sequencing (WGS) in the pediatric critical-care context, we examined how clinicians caring for critically ill children with congenital heart disease (CHD) anticipate and perceive the impact of WGS on their decision-making process and treatment recommendations.

methodsWe conducted semistructured in-person and telephone interviews of clinicians involved in the care of critically ill children with CHD at a high-volume pediatric heart center. We qualitatively analyzed the transcribed interviews.

resultsIn total, 34 clinicians were interviewed. Three themes emerged: (i) uncertainty about the accuracy of WGS testing and adequacy of testing validation; (ii) the use of WGS to facilitate life-limiting decisions such as futility, rationing, and selective prenatal termination; and (iii) moral distress over using WGS with a lack of decision support.

conclusionDespite uncertainty about WGS testing, the interviewed clinicians were using, and anticipated expanding the use of, WGS results to justify declarations of futility, withdrawal of care, and rationing in critically ill children with CHD. This situation is causing moral distress in providers who have to make high-stakes decisions involving WGS results, with only partial understanding of them. Decision support for clinicians, and discussion with families of the risks of using WGS for rationing or withdrawal, is needed.

Indexed as

Genetic TestingChildCritical CareCritical IllnessDecision MakingExome SequencingFemaleGenome, HumanHeart DiseasesHumansPediatricsSequence Analysis, DNAcritical carefutilitypediatricsrationingwhole-genome sequencing

Identifiers

PMID29493583
PMCPMC6119522
OpenAlexW2792089070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.